Oventus Medical Ltd. announced that it has received a Notice of Allowance from the US Patent and Trade Mark Office for application USSN14/118,416 relating to the company breathing assistance apparatus including an integrated airway. The integrated airway or Oventus Airway Technology' is incorporated into the company O2VentTM oral devices for the treatment of sleep apnoea and snoring. Oventus also has corresponding patent protection in place for its technology from the Australian Patent Office in the Australian market, and has also recently received a Notice of Allowance from the European Patent Office for Europe.